Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Non-Current Deferred Tax Liability (2018 - 2020)

Zevra Therapeutics' Non-Current Deferred Tax Liability history spans 5 years, with the latest figure at $476000.0 for Q4 2020.

  • For Q4 2020, Non-Current Deferred Tax Liability fell 11.85% year-over-year to $476000.0; the TTM value through Dec 2020 reached $476000.0, down 11.85%, while the annual FY2020 figure was $476000.0, 11.85% down from the prior year.
  • Non-Current Deferred Tax Liability reached $476000.0 in Q4 2020 per ZVRA's latest filing, down from $540000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $540000.0 in Q4 2019 to a low of $171000.0 in Q4 2018.
  • Average Non-Current Deferred Tax Liability over 3 years is $395666.7, with a median of $476000.0 recorded in 2020.
  • Peak YoY movement for Non-Current Deferred Tax Liability: skyrocketed 215.79% in 2019, then decreased 11.85% in 2020.
  • A 3-year view of Non-Current Deferred Tax Liability shows it stood at $171000.0 in 2018, then surged by 215.79% to $540000.0 in 2019, then fell by 11.85% to $476000.0 in 2020.
  • Per Business Quant, the three most recent readings for ZVRA's Non-Current Deferred Tax Liability are $476000.0 (Q4 2020), $540000.0 (Q4 2019), and $171000.0 (Q4 2018).